VERAXIS
RESEARCH

PRECISION
COMPOUNDS FOR
SERIOUS SCIENCE

Veraxis Research was founded on a single premise: researchers deserve compounds that perform exactly as specified. Too many studies are compromised by inconsistent purity, undocumented synthesis methods, or absent third-party verification. We built Veraxis to eliminate those variables.

Every compound we produce is synthesized under GMP conditions, verified by independent analytical laboratories, and shipped with a full Certificate of Analysis. No exceptions. No compromises.

HOW WE
VERIFY QUALITY

Our quality assurance process is not a checkbox — it is the foundation of every compound we release. Below are the standards applied to every batch, without exception.

Synthesis Method

All peptides are synthesized via solid-phase peptide synthesis (SPPS) using Fmoc chemistry. This method provides precise sequence control and high reproducibility across production batches.

Purity Verification

Every batch undergoes reverse-phase HPLC analysis at an independent third-party laboratory. Minimum purity threshold is 99% — batches below this standard are rejected and not released.

Identity Confirmation

Mass spectrometry (ESI-MS or MALDI-TOF) confirms molecular identity for every compound. Results are included in the Certificate of Analysis shipped with each order.

Endotoxin Testing

Compounds are tested using the Limulus Amebocyte Lysate (LAL) method. Endotoxin levels must be below 1 EU/mg to pass release criteria.

Storage & Stability

Lyophilized peptides are stable at −20°C for 24 months from manufacture date. Stability data is available upon request.

Regulatory Scope

All Veraxis compounds are classified as research-use-only (RUO) materials. They are not approved for human or veterinary use. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.